Lingya Pan

2.1k total citations
108 papers, 1.4k citations indexed

About

Lingya Pan is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Lingya Pan has authored 108 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Reproductive Medicine, 47 papers in Obstetrics and Gynecology and 20 papers in Oncology. Recurrent topics in Lingya Pan's work include Ovarian cancer diagnosis and treatment (48 papers), Endometrial and Cervical Cancer Treatments (39 papers) and Endometriosis Research and Treatment (18 papers). Lingya Pan is often cited by papers focused on Ovarian cancer diagnosis and treatment (48 papers), Endometrial and Cervical Cancer Treatments (39 papers) and Endometriosis Research and Treatment (18 papers). Lingya Pan collaborates with scholars based in China, United States and United Kingdom. Lingya Pan's co-authors include Ning Mao, Jie Yin, Xuedong Yan, Ying Shan, Ying Jin, Ying Jin, Yan Li, Jinghe Lang, Yili Yang and Huifang Huang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Fertility and Sterility.

In The Last Decade

Lingya Pan

102 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingya Pan China 22 590 494 491 236 228 108 1.4k
Lisa Barroilhet United States 21 393 0.7× 356 0.7× 357 0.7× 202 0.9× 216 0.9× 62 1.1k
Eiichiro Tominaga Japan 24 383 0.6× 648 1.3× 337 0.7× 481 2.0× 275 1.2× 66 1.4k
Sabrina Chiara Cecere Italy 20 525 0.9× 428 0.9× 261 0.5× 290 1.2× 615 2.7× 71 1.4k
Nobuhisa Yoshikawa Japan 18 384 0.7× 266 0.5× 209 0.4× 145 0.6× 253 1.1× 91 980
Aliza Leiser United States 13 301 0.5× 433 0.9× 213 0.4× 404 1.7× 335 1.5× 29 1.2k
E. A. Eisenhauer Canada 16 504 0.9× 357 0.7× 241 0.5× 149 0.6× 404 1.8× 31 1.2k
Johanna Mäenpää Finland 20 770 1.3× 278 0.6× 287 0.6× 134 0.6× 602 2.6× 75 1.3k
M Yakushiji Japan 23 772 1.3× 470 1.0× 465 0.9× 180 0.8× 417 1.8× 161 1.7k
Marilena Di Napoli Italy 16 374 0.6× 331 0.7× 210 0.4× 187 0.8× 433 1.9× 64 1.0k
Berno Tanner Germany 16 427 0.7× 503 1.0× 157 0.3× 195 0.8× 423 1.9× 27 1.1k

Countries citing papers authored by Lingya Pan

Since Specialization
Citations

This map shows the geographic impact of Lingya Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingya Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingya Pan more than expected).

Fields of papers citing papers by Lingya Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingya Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingya Pan. The network helps show where Lingya Pan may publish in the future.

Co-authorship network of co-authors of Lingya Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Lingya Pan. A scholar is included among the top collaborators of Lingya Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingya Pan. Lingya Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Xiaochen, Xianjie Tan, Shuiqing Ma, et al.. (2025). Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease. Annals of Medicine. 57(1). 2466667–2466667. 1 indexed citations
3.
Yin, Jie, Yiping Wen, Jing Zeng, et al.. (2022). CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells. BMC Cancer. 22(1). 903–903. 4 indexed citations
4.
Yang, Jie, Jiaxin Yang, Dongyan Cao, et al.. (2022). Management of stage I occult uterine leiomyosarcoma: effects of morcellation, second-look surgery, and adjuvant treatments on survival. Annals of Translational Medicine. 10(2). 127–127. 5 indexed citations
5.
Chen, Junyu, Dongyan Cao, Jiaxin Yang, et al.. (2022). Low-grade endometrial stromal sarcoma with intracaval or intracardiac extension: a retrospective study of eight cases. Archives of Gynecology and Obstetrics. 306(5). 1799–1806.
6.
Li, Yan, Ying Shan, Huanwen Wu, et al.. (2022). 30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease. Frontiers in Oncology. 12. 842703–842703. 13 indexed citations
7.
Yin, Jie, Shuai Ma, Ying Shan, et al.. (2020). Risk Factors for Recurrence in Patients with Atypical Endometrial Hyperplasia and Endometrioid Adenocarcinoma after Fertility-Sparing Treatments. Cancer Prevention Research. 13(4). 403–410. 11 indexed citations
8.
Yang, Jiaxin, Keng Shen, Huifang Huang, et al.. (2020). Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors. Archives of Gynecology and Obstetrics. 301(4). 1021–1026. 7 indexed citations
9.
Li, Siyi, Huifang Huang, Yan Li, et al.. (2020). A Comparison of Laparoscopies and Laparotomies for Radical Hysterectomy in Stage IA1-IB1 Cervical Cancer Patients: A Single Team With 18 Years of Experience. Frontiers in Oncology. 10. 1738–1738. 16 indexed citations
10.
Cai, Yan, Jie Yin, Ying Jin, et al.. (2019). Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study. European Journal of Surgical Oncology. 46(5). 876–882. 7 indexed citations
12.
Cao, Dongyan, Keng Shen, Yang Xiang, et al.. (2014). Neoadjuvant chemotherapy in locally advanced cervical carcinoma: which is better, intravenous or intra-arterial?. OncoTargets and Therapy. 7. 2155–2155. 5 indexed citations
13.
Wang, Jinhui, Jiaxin Yang, Huifang Huang, et al.. (2012). Management of Intravenous Leiomyomatosis With Intracaval and Intracardiac Extension. Obstetrics and Gynecology. 120(6). 1400–1406. 46 indexed citations
14.
Li, Min, Jie Yin, Ning Mao, & Lingya Pan. (2012). Upregulation of phosphorylated cofilin 1 correlates with taxol resistance in human ovarian cancer in vitro and in vivo. Oncology Reports. 29(1). 58–66. 34 indexed citations
15.
Yin, Jie, Xuedong Yan, Xin Yao, et al.. (2011). Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients. Journal of Cellular and Molecular Medicine. 16(2). 337–348. 106 indexed citations
16.
Dai, Yuxin, Jinghe Lang, Lan Zhu, et al.. (2010). [Microarray analysis of gene expression profiles in pelvic organ prolapse].. PubMed. 45(5). 342–7. 4 indexed citations
17.
Liu, Haiyuan, Lingya Pan, Keng Shen, et al.. (2009). Magnetic resonance imaging is useful for diagnosis and evaluation of recurrent intravenous leiomyomatosis before surgery. Fertility and Sterility. 92(3). 1150–1152. 4 indexed citations
18.
Yang, Jiaxin, Keng Shen, Ying Shan, et al.. (2008). Seven Cases of Epithelial Ovarian Carcinoma with Brain Metastasis. Chinese Medical Sciences Journal. 23(1). 19–22. 3 indexed citations
19.
Pan, Lingya. (2006). Characterization of TAXOL-resistance ovarian cancer cell lines induced by different administrations approaches. 2 indexed citations
20.
Pan, Lingya. (2003). Ototoxicity of Platinum Compounds. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026